FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209878863> ?p ?o ?g. }

• W3209878863 endingPage "141" @default.
• W3209878863 startingPage "133" @default.
• W3209878863 abstract "Metformin has known mechanistic benefits on COVID-19 infection due to its anti-inflammatory effects and its action on the ACE2 receptor. However, some physicians are reluctant to use it in hypoxemic patients due to potential lactic acidosis. The primary purpose of the study was to determine whether metformin use is associated with survival. We also wanted to determine whether there is a difference in outcomes in subcategories of metformin use, whether at home, in-hospital, or mixed home/in-hospital use.This study aimed to determine an association between metformin use and mortality among patients with type 2 diabetes mellitus hospitalized for COVID-19 infection.This was a cross-sectional analysis of data acquired from the COVID-19 database of two tertiary hospitals in Cebu from March 1, 2020, to September 30, 2020. Hospitalized adult Filipino patients with type 2 diabetes mellitus who tested positive for COVID-19 via RT-PCR were included and categorized as either metformin users or metformin non-users.We included 355 patients with type 2 diabetes mellitus in the study, 186 (52.4%) were metformin users. They were further categorized into home metformin users (n=109, 30.7%), in-hospital metformin users (n=40, 11.3%), and mixed home/in-hospital metformin users (n=37, 10.4%). Metformin use was associated with a lower risk for mortality compared to non-users (p=0.001; OR=0.424). In-hospital and mixed home/in-hospital metformin users were associated with lower mortality odds than non-users (p=0.002; OR=0.103 and p=0.005; OR 0.173, respectively). The lower risk for mortality was noted in metformin, regardless of dosage, from 500 mg to 2 g daily (p=0.002). Daily dose between ≥1000 mg to <2000 mg was associated with the greatest benefit on mortality (p≤0.001; OR=0.252). The survival distributions between metformin users and non-users were statistically different, showing inequality in survival (χ2=5.67, p=0.017).Metformin was associated with a lower risk for mortality in persons with type 2 diabetes mellitus hospitalized for COVID-19 disease compared to non-users. Use of metformin in-hospital, and mixed home/in-hospital metformin use, was also associated with decreased risk for mortality. The greatest benefit seen was in those taking a daily dose of ≥1000 mg to <2000 mg." @default.
• W3209878863 created "2021-11-08" @default.
• W3209878863 creator A5040079836 @default.
• W3209878863 creator A5053810137 @default.
• W3209878863 creator A5070682841 @default.
• W3209878863 creator A5080733774 @default.
• W3209878863 creator A5082168192 @default.
• W3209878863 date "2021-10-30" @default.
• W3209878863 modified "2023-10-06" @default.
• W3209878863 title "Association Between Metformin Use and Mortality Among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection" @default.
• W3209878863 cites W1995666039 @default.
• W3209878863 cites W2006434809 @default.
• W3209878863 cites W2020741797 @default.
• W3209878863 cites W2087910657 @default.
• W3209878863 cites W2141199290 @default.
• W3209878863 cites W2168172569 @default.
• W3209878863 cites W2271771390 @default.
• W3209878863 cites W2473725818 @default.
• W3209878863 cites W2900161504 @default.
• W3209878863 cites W2968818988 @default.
• W3209878863 cites W3004280078 @default.
• W3209878863 cites W3009912996 @default.
• W3209878863 cites W3010276220 @default.
• W3209878863 cites W3012180666 @default.
• W3209878863 cites W3018002427 @default.
• W3209878863 cites W3018735447 @default.
• W3209878863 cites W3021033505 @default.
• W3209878863 cites W3022646285 @default.
• W3209878863 cites W3023787531 @default.
• W3209878863 cites W3024219744 @default.
• W3209878863 cites W3025663760 @default.
• W3209878863 cites W3026508573 @default.
• W3209878863 cites W3027187955 @default.
• W3209878863 cites W3031959493 @default.
• W3209878863 cites W3040983336 @default.
• W3209878863 cites W3042070402 @default.
• W3209878863 cites W3073804858 @default.
• W3209878863 cites W3091085673 @default.
• W3209878863 cites W3097749910 @default.
• W3209878863 cites W3109186718 @default.
• W3209878863 cites W3111023021 @default.
• W3209878863 cites W3119033482 @default.
• W3209878863 cites W3133451197 @default.
• W3209878863 doi "https://doi.org/10.15605/jafes.036.02.20" @default.
• W3209878863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34966196" @default.
• W3209878863 hasPublicationYear "2021" @default.
• W3209878863 type Work @default.
• W3209878863 sameAs 3209878863 @default.
• W3209878863 citedByCount "11" @default.
• W3209878863 countsByYear W32098788632022 @default.
• W3209878863 countsByYear W32098788632023 @default.
• W3209878863 crossrefType "journal-article" @default.
• W3209878863 hasAuthorship W3209878863A5040079836 @default.
• W3209878863 hasAuthorship W3209878863A5053810137 @default.
• W3209878863 hasAuthorship W3209878863A5070682841 @default.
• W3209878863 hasAuthorship W3209878863A5080733774 @default.
• W3209878863 hasAuthorship W3209878863A5082168192 @default.
• W3209878863 hasBestOaLocation W32098788631 @default.
• W3209878863 hasConcept C126322002 @default.
• W3209878863 hasConcept C134018914 @default.
• W3209878863 hasConcept C156957248 @default.
• W3209878863 hasConcept C2777180221 @default.
• W3209878863 hasConcept C2780317664 @default.
• W3209878863 hasConcept C2780323712 @default.
• W3209878863 hasConcept C2910068830 @default.
• W3209878863 hasConcept C555293320 @default.
• W3209878863 hasConcept C71924100 @default.
• W3209878863 hasConceptScore W3209878863C126322002 @default.
• W3209878863 hasConceptScore W3209878863C134018914 @default.
• W3209878863 hasConceptScore W3209878863C156957248 @default.
• W3209878863 hasConceptScore W3209878863C2777180221 @default.
• W3209878863 hasConceptScore W3209878863C2780317664 @default.
• W3209878863 hasConceptScore W3209878863C2780323712 @default.
• W3209878863 hasConceptScore W3209878863C2910068830 @default.
• W3209878863 hasConceptScore W3209878863C555293320 @default.
• W3209878863 hasConceptScore W3209878863C71924100 @default.
• W3209878863 hasIssue "2" @default.
• W3209878863 hasLocation W32098788631 @default.
• W3209878863 hasLocation W32098788632 @default.
• W3209878863 hasLocation W32098788633 @default.
• W3209878863 hasOpenAccess W3209878863 @default.
• W3209878863 hasPrimaryLocation W32098788631 @default.
• W3209878863 hasRelatedWork W2021245895 @default.
• W3209878863 hasRelatedWork W2072097257 @default.
• W3209878863 hasRelatedWork W2077814385 @default.
• W3209878863 hasRelatedWork W2357816617 @default.
• W3209878863 hasRelatedWork W2410098307 @default.
• W3209878863 hasRelatedWork W2896984032 @default.
• W3209878863 hasRelatedWork W2940970186 @default.
• W3209878863 hasRelatedWork W3116386123 @default.
• W3209878863 hasRelatedWork W4283768941 @default.
• W3209878863 hasRelatedWork W72989260 @default.
• W3209878863 hasVolume "36" @default.
• W3209878863 isParatext "false" @default.
• W3209878863 isRetracted "false" @default.
• W3209878863 magId "3209878863" @default.
• W3209878863 workType "article" @default.